0001209191-17-030119.txt : 20170504
0001209191-17-030119.hdr.sgml : 20170504
20170504180210
ACCESSION NUMBER: 0001209191-17-030119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170503
FILED AS OF DATE: 20170504
DATE AS OF CHANGE: 20170504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Pharma plc
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272179987
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANTINI GINO
CENTRAL INDEX KEY: 0001276038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 17815520
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-03
0
0001492426
Horizon Pharma plc
HZNP
0001276038
SANTINI GINO
C/O HORIZON PHARMA PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
1
0
0
0
Ordinary Shares
2017-05-03
4
M
0
13953
A
17793
I
By Trust
Ordinary Shares
2017-05-03
4
F
0
5477
15.12
D
12316
I
By Trust
Restricted Stock Units
2017-05-03
4
M
0
13953
0.00
D
Ordinary shares
13953
0
D
Stock Option (Right to Buy)
15.12
2017-05-03
4
A
0
31153
0.00
A
2027-05-02
Ordinary shares
31153
31153
D
Restricted Stock Units
2017-05-03
4
A
0
14054
0.00
A
2018-05-03
Ordinary shares
14054
14054
D
Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
The option vests in 12 equal monthly installments from the date of grant.
/s/ Paul W. Hoelscher, Attorney-in-Fact
2017-05-04